Bruno Kovic

558 total citations
9 papers, 322 citations indexed

About

Bruno Kovic is a scholar working on Genetics, Oncology and Economics and Econometrics. According to data from OpenAlex, Bruno Kovic has authored 9 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 4 papers in Oncology and 3 papers in Economics and Econometrics. Recurrent topics in Bruno Kovic's work include Health Systems, Economic Evaluations, Quality of Life (3 papers), Acute Myeloid Leukemia Research (2 papers) and Advanced Breast Cancer Therapies (2 papers). Bruno Kovic is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (3 papers), Acute Myeloid Leukemia Research (2 papers) and Advanced Breast Cancer Therapies (2 papers). Bruno Kovic collaborates with scholars based in Canada, Switzerland and United States. Bruno Kovic's co-authors include Feng Xie, Xiaoning He, Mengxiao Wang, Xuejing Jin, Qinshu Lian, Carlos H. Barrios, Zbigniew Nowecki, Steven J. Isakoff, Rebecca Dent and Joyce O’Shaughnessy and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Hepatology.

In The Last Decade

Bruno Kovic

8 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruno Kovic Canada 8 129 73 63 61 58 9 322
Mayssam Moussa Lebanon 9 96 0.7× 86 1.2× 119 1.9× 81 1.3× 19 0.3× 13 418
A. Nielsen Denmark 12 65 0.5× 75 1.0× 88 1.4× 31 0.5× 12 0.2× 28 328
Alessio Biazzo Italy 11 100 0.8× 100 1.4× 152 2.4× 14 0.2× 35 0.6× 26 385
Yuko Waguri‐Nagaya Japan 14 193 1.5× 132 1.8× 146 2.3× 18 0.3× 15 0.3× 60 519
Alfonso Berrocal Spain 12 27 0.2× 74 1.0× 92 1.5× 76 1.2× 39 0.7× 30 381
Lize F. D. van Vulpen Netherlands 14 70 0.5× 107 1.5× 111 1.8× 233 3.8× 19 0.3× 50 806
Rachel Lakey United Kingdom 10 218 1.7× 165 2.3× 43 0.7× 17 0.3× 58 1.0× 13 498
Takaaki Chin Japan 9 86 0.7× 235 3.2× 128 2.0× 23 0.4× 38 0.7× 13 549
Sheila Piva Italy 11 139 1.1× 118 1.6× 86 1.4× 16 0.3× 54 0.9× 27 588
Tao Zheng China 12 50 0.4× 76 1.0× 127 2.0× 14 0.2× 97 1.7× 42 501

Countries citing papers authored by Bruno Kovic

Since Specialization
Citations

This map shows the geographic impact of Bruno Kovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Kovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Kovic more than expected).

Fields of papers citing papers by Bruno Kovic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno Kovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Kovic. The network helps show where Bruno Kovic may publish in the future.

Co-authorship network of co-authors of Bruno Kovic

This figure shows the co-authorship network connecting the top 25 collaborators of Bruno Kovic. A scholar is included among the top collaborators of Bruno Kovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruno Kovic. Bruno Kovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
2.
3.
Mascarenhas, John, Francesco Passamonti, Kate Burbury, et al.. (2021). The MDM2 antagonist idasanutlin in patients with polycythemia vera: results from a single-arm phase 2 study. Blood Advances. 6(4). 1162–1174. 16 indexed citations
4.
Turner, Nicholas C., Rebecca Dent, Joyce O’Shaughnessy, et al.. (2021). Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer: primary results from cohort B of the IPATunity130 randomized phase 3 trial. Breast Cancer Research and Treatment. 191(3). 565–576. 64 indexed citations
5.
Mascarenhas, John, Brian Higgins, Doreen Anders, et al.. (2020). Safety and Efficacy of Idasanutlin in Patients (pts) with Hydroxyurea (HU)-Resistant/Intolerant Polycythemia Vera (PV): Results of an International Phase II Study. Blood. 136(Supplement 1). 29–31. 9 indexed citations
6.
Kovic, Bruno, et al.. (2017). Deficiencies in addressing effect modification in network meta-analyses: a meta-epidemiological survey. Journal of Clinical Epidemiology. 88. 47–56. 10 indexed citations
7.
Kovic, Bruno, Gordon Guyatt, Michael Brundage, et al.. (2016). Association between progression-free survival and health-related quality of life in oncology: a systematic review protocol. BMJ Open. 6(9). e012909–e012909. 9 indexed citations
8.
Xie, Feng, et al.. (2016). Economic and Humanistic Burden of Osteoarthritis: A Systematic Review of Large Sample Studies. PharmacoEconomics. 34(11). 1087–1100. 162 indexed citations
9.
Kovic, Bruno & Feng Xie. (2015). Economic Evaluation of Bevacizumab for the First-Line Treatment of Newly Diagnosed Glioblastoma Multiforme. Journal of Clinical Oncology. 33(20). 2296–2302. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mayssam Moussa Breakdown of academic impact, for papers by A. Nielsen Breakdown of academic impact, for papers by Alessio Biazzo Breakdown of academic impact, for papers by Yuko Waguri‐Nagaya Breakdown of academic impact, for papers by Alfonso Berrocal Breakdown of academic impact, for papers by Lize F. D. van Vulpen Breakdown of academic impact, for papers by Rachel Lakey Breakdown of academic impact, for papers by Takaaki Chin Breakdown of academic impact, for papers by Sheila Piva Breakdown of academic impact, for papers by Tao Zheng
Rankless by CCL
2026